Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:514-519

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, T.
Right arrow Articles by Nishikibe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, T.
Right arrow Articles by Nishikibe, M.
Related Collections
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Receptor pharmacology

(Hypertension. 1999;34:514-519.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Pathophysiological Roles of Endothelin-1 in Dahl Salt-Sensitive Hypertension

Takanori Ikeda; Hisashi Ohta; Megumu Okada; Nobuko Kawai; Rumi Nakao; Peter K. S. Siegl; Tsutomu Kobayashi; Seiji Maeda; Takashi Miyauchi; Masaru Nishikibe

From the Department of Pharmacology, Tsukuba Research Institute, Banyu Pharmaceutical Co Ltd (T.I., H.O., M.O., N.K., R.N., T.K., M.N.); Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba (S.M., T.M.), Ibaraki, Japan; and Department of Cardiovascular Pharmacology, Merck Research Laboratories (P.K.S.S.), West Point, Penn.

Correspondence to Masaru Nishikibe, PhD, Department of Pharmacology, Development Research Laboratories, Tsukuba Research Institute, Banyu Pharmaceutical Co Ltd, Okubo 3, Tsukuba, Ibaraki 300-2611, Japan. E-mail niskbems{at}banyu.co.jp

Abstract—The purpose of the present experiment was to study the pathophysiological roles of endothelin-1 (ET-1) in salt-sensitive hypertension with the use of Dahl salt-sensitive (DS) and salt-resistant (DR) rats. PreproET-1 mRNA expression was determined by reverse transcription–polymerase chain reaction. In the kidney, expression of preproET-1 mRNA was greater in DS rats on a normal salt diet compared with DR rats of the same age. In DS rats, the level of preproET-1 mRNA expression in kidney had a significant correlation with systolic blood pressure. The expression of preproET-1 mRNA in aorta and kidney was increased by 3-week high salt intake in DS rats but not in DR rats. Expression of preproET-1 mRNA and ET-1 levels in left ventricle was exaggerated by high salt intake in DS rats. However, there was no significant difference in plasma ET-1 levels between DS and DR rats regardless of salt intake. Pressor response curves for ET-1 in DS rats with or without high salt intake were significantly shifted to the left compared with those in DR rats. A single oral dose (3 to 10 mg/kg) of J-104132 (L-753 037), a potent, orally active mixed endothelin A and B (ETA/ETB) receptor antagonist, reduced blood pressure to normotensive levels in DS rats with high salt intake, and its action was maintained for >=24 hours. In DS rats with normal salt intake, J-104132 (10 mg/kg) slightly but significantly decreased blood pressure. DR rats did not show obvious depressor responses to J-104132 (10 mg/kg) regardless of salt intake. These results suggest that ET-1 acts as one of the pathophysiological factors in the development and maintenance of salt-sensitive hypertension, and a mixed ETA/ETB receptor antagonist could be useful in the treatment for salt-sensitive hypertension.


Key Words: endothelin • hypertension • rats, Dahl • kidney • receptors, endothelin




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. P. Schneider, E. W. Inscho, and D. M. Pollock
Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1208 - F1214.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Quaschning, F. Voss, K. Relle, P. Kalk, N. Vignon-Zellweger, T. Pfab, C. Bauer, F. Theilig, S. Bachmann, A. Kraemer-Guth, et al.
Lack of Endothelial Nitric Oxide Synthase Promotes Endothelin-Induced Hypertension: Lessons from Endothelin-1 Transgenic/Endothelial Nitric Oxide Synthase Knockout Mice
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 730 - 740.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Chansel, M. Ciroldi, S. Vandermeersch, L. F Jackson, A.-M. Gomez, D. Henrion, D. C. Lee, T. M. Coffman, S. Richard, J.-C. Dussaule, et al.
Heparin binding EGF is necessary for vasospastic response to endothelin
FASEB J, September 1, 2006; 20(11): 1936 - 1938.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. D'Angelo, J. S. Pollock, and D. M. Pollock
In vivo evidence for endothelin-1-mediated attenuation of {alpha}1-adrenergic stimulation
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1251 - H1258.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
V. L. M. Herrera, L. R. B. Ponce, P. D. Bagamasbad, B. D. VanPelt, T. Didishvili, and N. Ruiz-Opazo
Embryonic lethality in Dear gene-deficient mice: new player in angiogenesis
Physiol Genomics, November 17, 2005; 23(3): 257 - 268.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
C. P. del Villar, C. J. G. Alonso, C. A. Feldstein, L. A. Juncos, and J. C. Romero
Role of Endothelin in the Pathogenesis of Hypertension
Mayo Clin. Proc., January 1, 2005; 80(1): 84 - 96.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. A. Fenton, C.-L. Chou, S. Ageloff, W. Brandt, J. B. Stokes, and M. A. Knepper
Increased collecting duct urea transporter expression in Dahl salt-sensitive rats
Am J Physiol Renal Physiol, July 1, 2003; 285(1): F143 - F151.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Ballew, S. W. Watts, and G. D. Fink
Effects of Salt Intake and Angiotensin II on Vascular Reactivity to Endothelin-1
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 345 - 350.
[Abstract] [Full Text]